Cellular Id1 inhibits hepatitis B virus transcription by interacting with the novel covalently closed circular DNA-binding protein E2F4

Hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC), which required developing novel therapies targeting the inhibition of HBV transcription and replication due to current limited treatment options. We explored novel target for the development of novel therapi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jie, Shi, Yueyuan, Zou, Chunhong, Zhang, Hongpeng, Peng, Hui, Wang, Shilei, Xia, Lulu, Yang, Yuan, Zhang, Xiang, Liu, Junye, Zhou, Hua, Luo, Miao, Huang, Ailong, Wang, Deqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692152/
https://www.ncbi.nlm.nih.gov/pubmed/34975318
http://dx.doi.org/10.7150/ijbs.62106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692152/
https://www.ncbi.nlm.nih.gov/pubmed/34975318
http://dx.doi.org/10.7150/ijbs.62106

Ejemplares similares